Lantheus Holdings, Inc.
LNTH- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001521036
No open-market purchases or sales by Lantheus Holdings, Inc. insiders were filed in the last 90 days; 467 institutions reported holding it in 13F filings for Q2 2026, worth $8.34B in total; no superinvestor holds it.
Superinvestors holding LNTH, Q2 2026
No superinvestor reported holding LNTH in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of LNTH each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+29.0%)
Q4 2022
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+76.1%)
Q3 2022
1 superinvestor holding at quarter end